Drug distributors, J&J agree to finalize $26 bln opioid settlement
Source: Reuters
Feb 25 (Reuters) - The three largest U.S. drug distributors and drugmaker Johnson & Johnson (JNJ.N) have agreed to finalize a proposed $26 billion settlement resolving claims by states and local governments that they helped fuel the U.S. opioid epidemic.
Distributors McKesson Corp (MCK.N), AmerisourceBergen Corp (ABC.N), Cardinal Health Inc (CAH.N) along with J&J had until Friday to decide whether enough cities and counties nationally had opted to join the landmark settlement to justify moving forward with it.
The deal aims to resolve more than 3,000 lawsuits largely by state and local governments seeking to hold the companies responsible for an opioid abuse crisis that has led to hundreds of thousands of overdose deaths over the last two decades.
The announcement paves the way for the companies to begin making payments to the governments in April, money that officials say will be used to fund treatment and other programs aimed at addressing the health crisis.
Read more: https://www.reuters.com/legal/litigation/drug-distributors-agree-finalize-opioid-settlement-2022-02-25/